参考文献/References:
[1] Lauridsen M M,Thacker L R,White M B,et al.In patientswith cirrhosis,driving simulator performance is associatedwith real-life driving[J].Clin Gastroenterol Hepatol,2016,14(5):747-752.[2] Souto P A,Marcotegui A R,Orbea L,et al.Hepatic encephalopathy:Ever closer to its big bang[J].World Journal of Gastroenterology,2016,22(42):9251-9256.[3] Schulz C,Schutte K,Kropf S,et al.RiMINI - the influence ofrifaximin on minimal hepatic encephalopathy (MHE) andon the intestinal microbiome in patients with liver cirrhosis:study protocol for a randomized controlled trial[J].Trials,2016,17(1):111.[4] 杨廷旭,高毅英,康发财,等.轻微肝性脑病区域性流行病学调查及中西医结合干预研究[J].中国临床研究,2015,28(4):540-542.[5] 苏常春,麦玉冰,曾峥,等.亚临床肝性脑病患者 BAEP 的研究[J].临床神经电生理学杂志,2008(3):157-159.[6] Ferenci P,Lockwood A,Mullen K,et al.Hepatic encephalopa-thy-Definition,nomenclature,diagnosis,and quantificatio[J].Hepatology,2002,35(3):716-721.[7] 中华医学会肝病学分会.肝硬化肝性脑病诊疗指南[J].临床肝胆病杂志,2018,34(10):2076-2089.[8] 王军,张流,熊华刚,等.醒脑静联合纳洛酮治疗肝性脑病患者认知和血清炎症因子水平变化[J].实用肝脏病杂志,2018,21(3):471-472.[9] Labenz C,Baron J S,Toenges G,et al.Prospective evaluationof the impact of covert hepatic encephalopathy on quality oflife and sleep in cirrhotic patients[J].Alimentary Pharmacology& Therapeutics,2018,48(3):313-321.[10] Sharon G,Sampson T R,Geschwind D H,et al.The CentralNervous System and the Gut Microbiome[J].Cell,2016,167(4):915-932.[11] Borrelli L,Aceto S,Agnisola C,et al.Probiotic modulation ofthe microbiota-gut-brain axis and behaviour in zebrafish[J].Scientific Reports,2016,6:30046.[12] Macpherson A,Heikenwalder M,Ganal-Vonarburg S.Theliver at the nexus of host-microbial interactions[J].Cell Host& Microbe,2016,20(5):561-571.[13] 陆伦根.肝性脑病:离我们并不遥远[J].中华消化杂志,2017(8):508-512.[14] Holecek,Milan.Evidence of a vicious cycle in glutaminesynthesis and breakdown in pathogenesis of hepaticencephalopathy-therapeutic perspectives[J].Metabolic BrainDisease,2014,29(1):9-17..[15] Clayton M.Hepatic encephalopathy:causes and health- relatedburden[J].British Journal of Nursing,2018,27(Sup3):S4-S6.[16] Bajaj J S,Ridlon J M,Hylemon P B,et al.Linkage of gutmicrobiome with cognition in hepatic encephalopathy[J].American Journal of Physiology Gastrointestinal and LiverPhysiology,2012,302(1):168-75.[17] Janve V S,Hernandez C C,Verdier K M,et al.Epilepticencephalopathy de novo GABRB mutations impair GABAAreceptor function[J].Annals of Neurology,2016,79(5):806-825.[18] 王家珑,李绍白.肝脏病学[M].北京:人民卫生出版社,2013:358-363.[19] Dhanda S,Gupta S,Halder A,et al.Systemic inflammationwithout gliosis mediates cognitive deficits through impairedBDNF expression in bile duct ligation model of hepaticencephalopathy[J].Brain Behavior and Immunity,2018,70(5):214-232[20] Arias N,Méndez M,Alcalde I,et al.Assessing the brainthrough the eye:New ways to explore hepatic encephalopathy[J].Physiology & Behavior,2017,173(5):263-271.[21] Arias N,Méndez M,Gómez-Lázaro E,et al.Main target ofminimal hepatic encephalopathy:Morphophysiological,inflammatory and metabolic view[J].Physiology & amp;Behavior,2015,149(10):247- 254.[22] Sharon G,Sampson T R,Geschwind D H,et al.The centralnervous system and the gut microbiome[J].Cell,2016,167(4):915-932.[23] Fu Z D,Cui J Y.Remote sensing between liver and intestine:Importance of microbial metabolites[J].Current PharmacologyReports,2017(3):101-113.[24] Marshall J C.The gut as a potential trigger of exercise-induced inflammatory responses[J].Canadian Journal ofPhysiology and Pharmacology,1998,76(5):479-484.[25] Sampson T R,Mazmanian S K.Control of brain development,function,and behavior by the microbiome[J].Cell HostMicrobe,2015,17(5):565-576.[26] Williams B B,Van Benschoten A H,Cimermancic P,etal.Discovery and characterization of gut microbiotadecarboxylases that can produce the neurotransmittertryptamine[J].Cell Host Microbe,2014,16(4):495-503.[27] Holzer P.Neuropeptides,Microbiota,and Behavior[J].Int RevNeurobiol,2016,131:67-89.[28] Gareau M G.Cognitive Function and the Microbiome[J].IntRev Neurobiol,2016,131:227-246.[29] Frederick RT.Current concepts in the pathophysiology andmanagement of hepatic encephalopathy[J].GastroenterolHepatol,2011,7 (4):222-233.[30] LIANG Shuwen,QU Changmin,WANG Xiaoying,et al.Clinical research on intestinal flora changes in patients withhepatic encephalopathy[J].J Med Res,2015,44 (11):68-70.[31] Qin J,Li R,Raes J,et al.A human gut microbial gene catalogueestablished by metagenomic sequencing[J].Nature,2010,464(7285):59-65.[32] 杨育林,沈雁,杨法根,等.微生态制剂联合肠内营养治疗肝性脑病的临床研究[J].中国中西医结合消化杂志,2014,22(4):173-177.[33] 朱小区,吴春明,陶玉,等.清腑灌肠方保留灌肠对肝性脑病患者 LPS、TNF-α 和 IL-6 的影响[J].中国中医急症,2014,23(3):389-390.[34] Wijarnpreecha K,Chesdachai S,Thongprayoon C,et al,.Association of helicobacter pylori with the risk of hepaticencephalopathy[J].Dig Dis Sci,2017,62(12):3614-3621.
相似文献/References:
[1]李瑞祥 陈斯宁.中医药对 COPD 大鼠模型作用机理的研究进展[J].大众科技,2014,16(05):95.
[2]李开富,蒋燕丽,庞 娣,等.轻微型肝性脑病中西医治疗探讨[J].大众科技,2019,21(09):54.
Research Progress on the Treatment of Minimal Hepatic Encephalopathy withTraditional Chinese and Western Medicine[J].Popular Science & Technology,2019,21(04):54.
[3]张 莉,张小蒙,周 敏.多年龄段痤疮的分层诊疗以及酒渣鼻关联性分析的研究进展[J].大众科技,2019,21(10):56.
Research Progress in the Treatment of Multistage Acne and Rosacea Correlation Analysis[J].Popular Science & Technology,2019,21(04):56.
[4]李开富,王 萌,黄国初.解毒化瘀方对轻微型肝性脑病患者血清代谢物谱的干预作用研究[J].大众科技,2019,21(10):60.
Study on the Intervention Effect of Jieduhuayu Granules on Serum Metabolite in Patients with Minimal Hepatic Encephalopathy[J].Popular Science & Technology,2019,21(04):60.
[5]李 珊.多囊卵巢综合征的发病机制及中西医疗法研究进展[J].大众科技,2021,23(1):71.
Advances in the Pathogenesis of Polycystic Ovary Syndrome and the Treatment of Traditional Chinese and Western Medicine[J].Popular Science & Technology,2021,23(04):71.
[6]吴铁雄 刘旭东 朱沪敏 黄 露 李品桦 庞华珍.非酒精性脂肪性肝病对肾功能指标影响的研究进展[J].大众科技,2021,23(6):63.
Research Progress on the Influence of Non-alcoholic Fatty Liver Disease on Renal Function Index[J].Popular Science & Technology,2021,23(04):63.
[7]韦柳婷 胡振斌 高松林 黄玲珊 韦湘红 张家增.中医药治疗非酒精性脂肪肝病的研究进展[J].大众科技,2023,25(3):85.
Research Progress of Traditional Chinese Medicine in the Treatment of Non-Alcoholic Fatty Liver Disease[J].Popular Science & Technology,2023,25(04):85.